In other words, the major output of the industry is not important new drugs, but minor variations of drugs that are already on the market – called copycat or “me-too” drugs. For example, the top-selling drug in the world, Pfizer’s Lipitor, is the fourth of six cholesterol-lowering drugs of the same type.